ProfessorGregory Woods

Emeritus Professor

Menzies Institute for Medical Research

  • Emeritus Professor
    Menzies Institute for Medical Research
  • +61 3 6226 4832 (Work)
  • Menzies Institute for Medical Research, Menzies Institute for Medical Research, 437C Medical Science 2 (MS2), Hobart CBD Campuses, TAS

FUNDED PROJECTS

  • GRANT
    Development of an immunology toolbox to combat emerging marsupial diseases
    1 Oct 2024 - 30 Sep 2027
    People funded by this grant:
    • Flies A,
    • Pye R,
    • Woods G,
    • Palmieri C,
    • Cragg M
    Project Total: $500,495; Australia is home to hundreds of marsupial species found nowhere else in the world. Unfortunately, disease is increasingly threatening Australias unique species. For example, the first Tasmanian devil facial tumour (DFT1) discovered in 1996 has led to 82% declines in regional devil populations. In 2014 a second type of devil facial tumour (DFT2) was discovered on a peninsula in southern Tasmania and is now starting to spread. COVID-19 vaccines were rolled out in less than a year and saved 14 million lives in 2021. A DFT1 vaccine like one of the most widely used COVID-19 vaccines has been developed, but better immunology tools are needed for the DFT1 vaccine trials and to accelerate DFT2 vaccine development. This project will use an innovative multispecies approach to develop advanced tools that will be used for devils and many other marsupial species. They can be used to help animals that contribute to human well-being and generate substantial economic benefits through tourism and ecosystem services. The project will generate highly-skilled students and researchers that are competitive in the international biotech sector. This project will move the whole field of animal immunology forward by making high-quality, low-cost immunology tools available to Australian researchers. The research team works closely with the Tasmanian government and stakeholders to ensure the research is translated into practice. Funded by: Australian Research Council - Grant-Discovery Projects ($500,625); University of Tasmania ($141,980).
  • CONSULTANCY/CONTRACT RESEARCH
    Advice to the AAD (PMU) re RTA in a COVID19 Environment
    1 Jan 2020 - 8 Mar 2021
    People funded by this grant:
    • Zosky G,
    • Flies A,
    • Woods G,
    • Norris K
    Project Total: $10,000; Literature review and recommendations to the Australian Antarctic Division regarding the Return to Australia for current Antarctic Expeditioners in a COVID19 environment. Funded by: Australian Antarctic Division ($10,000); University of Tasmania.
  • GRANT
    Immunisation to protect against transmissible cancers in Tasmanian devils
    14 Jul 2018 - 31 Dec 2021
    People funded by this grant:
    • Woods G,
    • Lyons B,
    • Corcoran L,
    • Hayball J,
    • Murphy J
    Project Total: $303,931; Funded by: Australian Research Council - Grant-Discovery Projects ($303,931); University of Tasmania ($39,450).
  • GRANT
    Identification of devil facial tumour-associated antigens for vaccine development
    1 Apr 2018 - 30 Mar 2020
    People funded by this grant:
    • Flies A,
    • Woods G,
    • Lyons B,
    • Wilson R
    Project Total: $34,256; The current DFTD vaccine can induce anti-DFTD immune responses, but the scalability and efficacy of the vaccine needs to be improved to deliver a broad conservation impact. This proposal builds on ongoing vaccine research to identify tumour-associated antigens that can be used to produce a highly replicable and scalable DFTD vaccine. Funded by: University of Tasmania Foundation Inc - Grant-Dr Eric Guiler Tasmanian Devil Research Gran; University of Tasmania ($34,256).
  • GRANT
    Advanced high resolution biomolecular analysis facility for Tasmania
    1 Jan 2018 - 31 Dec 2018
    People funded by this grant:
    • Smith S,
    • Paull B,
    • Woods G,
    • King A,
    • Wilson R
    Project Total: $350,790; This proposal seeks support for an advanced, multi-purpose mass spectrometry platform for high-throughput and targeted biomolecular analysis, including proteomics and metabolomics. The intended purpose of the proposed infrastructure is to provide a centralised state-of-the-art facility that supports internationally competitive research programs in plant science, agricultural research, food safety, animal and human health research and separation science at the University of Tasmania (UTAS) and within the broader Tasmanian scientific community. The anticipated benefit is a greatly enhanced capacity for leading edge research of national significance that aligns with the UTAS strategic research plan and national priorities. Funded by: Australian Research Council - Grant-Linkage Infrastructure ($350,790); University of Tasmania ($708,456).
  • GRANT
    Good cells battling bad cells: Cell-mediated immunity and transmissible cancer in the Tasmanian devil
    1 Sep 2017 - 30 Dec 2021
    People funded by this grant:
    • Lyons B,
    • Woods G,
    • Espejo C
    Project Total: $17,609; This project is focused in investigating the cell-mediated immunity in wild devils and its relation to DFTD, contributing complementary and relevant information to the current efforts to the vaccine development against DFTD. Funded by: Holsworth Wildlife Research Endowment - Grant ($17,609); University of Tasmania.
  • GRANT
    Evaluating the benefits in Tasmanian devils of immune responses to transmissible cancer
    17 May 2017 - 16 Sep 2018
    People funded by this grant:
    • Jones M,
    • Hamede Ross R,
    • Carver S,
    • Woods G
    Project Total: $25,000; A one year field and laboratory study to further our work on the evolution of resistance and tolerance in Tasmanian devils to facial tumor disease and to advance knowledge of immunology of devils for vaccine research. This work is a collaboration between the School of Biological Sciences and the Menzies Institute for Medical Research. Funded by: University of Tasmania Foundation Inc - Grant-Dr Eric Guiler Tasmanian Devil Research Gran; University of Tasmania ($25,000).
  • GRANT
    Distribution, prevalence and epidemiology of DFTD and DFT2 on the d Entrecasteaux channel area
    2 Mar 2017 - 31 Dec 2018
    People funded by this grant:
    • Hamede Ross R,
    • Jones M,
    • Woods G,
    • Darby J
    Project Total: $31,130; Two different transmissible cancers (DFTD and DFT2) are present in south-eastern Tasmania. This study will assess the distribution, prevalence, infection dynamics and survival after infection in both cancers. This information will create a baseline dataset for evaluating the threat of DFT2 and its possible interactions and selective processes with DFTD. Funded by: University of Tasmania Foundation Inc - Grant-Dr Eric Guiler Tasmanian Devil Research Gran; University of Tasmania ($31,130).
  • GRANT
    A live-attenuated vaccine (DFT-Off) to promote long-term anti-DFTD immunity
    1 Mar 2017 - 30 Jun 2018
    People funded by this grant:
    • Flies A,
    • Woods G,
    • Lyons B
    Project Total: $35,000; We have developed a system that allows us to switch genes on/off in devil facial tumour (DFT) cells. The DFT-Off? cells have the potential to be used as a live-attenuated vaccine, which generally perform better than killed vaccines, that provides long-term protection against both forms of DFT disease (DFTD). Funded by: University of Tasmania Foundation Inc - Grant-Dr Eric Guiler Tasmanian Devil Research Gran; University of Tasmania ($35,000).
  • GRANT
    CRISPR screen to identify key genes driving DFTD
    1 Mar 2017 - 1 Mar 2018
    People funded by this grant:
    • Hewitt A,
    • Liu G-S,
    • Woods G,
    • Flies A,
    • Cook T
    Project Total: $33,500; We will apply leading genomic techniques to identify the genes essential for the proliferation of the Tasmanian Devil Facial Tumour. By systematically disrupting each gene in the cancer, we will also identify genes which help the tumour evade the immune system. Funded by: University of Tasmania Foundation Inc - Grant-Dr Eric Guiler Tasmanian Devil Research Gran; University of Tasmania ($33,500).
  • GRANT
    Deciphering the cellular origin of the second Devil Facial Tumour Disease (DFT2)
    1 Mar 2017 - 30 Jun 2018
    People funded by this grant:
    • Woods G,
    • Tovar Lopez C,
    • Wilson R,
    • McKay M,
    • Papenfuss A
    Project Total: $34,165; We have established a multifaceted study to understand the cellular origin of DFT2 by producing large datasets with gene and protein profiles for DFT1 and DFT2. This proposal will use bioinformatics tools for the analysis of these data and the interpretation of the results in order to promote a more comprehensive understanding of the biology of DFTD Funded by: University of Tasmania Foundation Inc - Grant-Dr Eric Guiler Tasmanian Devil Research Gran; University of Tasmania ($34,165).
  • GRANT
    Developing DFTD vaccination approaches to favour cell mediated anti-tumour immunity
    1 Mar 2017 - 31 Dec 2019
    People funded by this grant:
    • Lyons B,
    • Patchett A,
    • Woods G
    Project Total: $32,304; To successfully vaccinate Tasmanian devils against DFTD, a particular form of response known as cell mediated immunity is needed. This project will test the ability of two distinct approaches to enhance cell mediated immune responses against DFTD. Funded by: University of Tasmania Foundation Inc - Grant-Dr Eric Guiler Tasmanian Devil Research Gran; University of Tasmania ($32,304).
  • GRANT
    Evaluation of the role natural killer (NK) cells in protection against DFTD
    1 Mar 2017 - 30 Jun 2018
    People funded by this grant:
    • Woods G,
    • Lyons B,
    • Flies A
    Project Total: $26,487; Natural Killer (NK) cells have a major role in the first line of defence against cancer. This project will investigate the presence and function of NK cells in the Tasmanian devil. The ultimate goal is to determine if NK cells are involved in the rejection of DFTD tumours. Funded by: University of Tasmania Foundation Inc - Grant-Dr Eric Guiler Tasmanian Devil Research Gran; University of Tasmania ($26,487).
  • GRANT
    Proteomics for Tasmanian devils: a DFTD pre-clinical test
    1 Mar 2017 - 28 Feb 2018
    People funded by this grant:
    • Wilson R,
    • Hamede Ross R,
    • Woods G
    Project Total: $15,000; Proteins within the circulatory system offer insight into the pathophysiology of an individual, and protein biomarkers are frequently the basis for clinical diagnostic tests. This project will use proteomics to compare serum from non-infected and DFTD-infected Tasmanian devils to identify a DFTD-specific protein signature that could be used to develop a diagnostic test for early detection of DFTD. Funded by: University of Tasmania Foundation Inc - Grant-Dr Eric Guiler Tasmanian Devil Research Gran; University of Tasmania ($15,000).
  • GRANT
    Detection of activated Tasmanian devil cytotoxic lymphocytes by a rapid RNA detection assay
    1 Jan 2016 - 31 Dec 2016
    People funded by this grant:
    • Pinfold T,
    • Bettiol S,
    • Woods G,
    • Lyons B
    Project Total: $34,999; Monitoring the immune response of vaccinated Tasmanian devils requires analysis of cell mediated immunity . The current assays we use demonstrate killing of DFTD cells but fail to reveal cytotoxic cell activation and the means of cell death. We plan incorporate a new assay that employs fluorescent in situ hybridisation and branched DNA amplification technique for simultaneous measurement of RNA transcripts in single cells using flow cytometry. The advantages of the proposed assay is that it provides a rapid and biologically relevant analysis of fresh blood samples taken from Tasmanian devils and measures the activity level of these cells equivalent to when they were in circulation. This will determine if cytotoxic cells are activated to induce target cell death. We will be able to analyse key gene expression markers for activation such as IFN-gamma and LAMP-I. Funded by: University of Tasmania Foundation Inc - Grant-Dr Eric Guiler Tasmanian Devil Research Gran; University of Tasmania ($34,999).
  • GRANT
    Improving the DFTD vaccine by targeting key immune signalling molecules
    1 Jan 2016 - 31 Dec 2017
    People funded by this grant:
    • Flies A,
    • Woods G,
    • Lyons B
    Project Total: $35,000; We have discovered that our current vaccine approach of using interferon-gamma (IFNg) to make the DFTD tumour cells visible to the devil immune system also induces upregulation of molecules that inhibit anti-tumour immune responses. We are now modifying the vaccine to counteract the effects of the inhibitory molecules. Funded by: University of Tasmania Foundation Inc - Grant-Dr Eric Guiler Tasmanian Devil Research Gran; University of Tasmania ($35,000).
  • GRANT
    Tasmanian Devil Vaccine research
    1 Jan 2016 - 31 Dec 2020
    People funded by this grant:
    • Woods G,
    • Lyons B
    Project Total: $537,451; To develop a vaccine against Devil Facial Tumour Disease Funded by: University of Tasmania Foundation Inc - Donation; University of Tasmania ($537,451).
  • CONSULTANCY/CONTRACT RESEARCH
    Translating human cancer immunotherapy techniques for use in pets and Tasmanian devils
    1 Jan 2016 - 31 Dec 2017
    People funded by this grant:
    • Flies A,
    • Woods G,
    • Lyons B,
    • Hayball J
    Project Total: $140,000; Immunotherapeutics targeting PD-1 and CTLA4 have shown unprecedented success in treating human cancers. Surprisingly, little is known to date on the potential for translating these human immunotherapy approaches into cancer treatments for veterinary medicine. The Tasmanian devil facial tumours (DFTs) and canine transmissible venereal tumour (CTVT) provide unique opportunities to assess immunotherapeutic treatment regimens for two naturally occurring tumours. Our ongoing work on the DFT has already developed ten anti-PD-1, nine anti-PD-L1 (aka B7-H1), and four anti-CTLA4 monoclonal antibodies (mAbs) that are highly specific for devil proteins. We have developed a system that can be used to rapidly generate new mAbs against additional target proteins. Importantly, this system can be readily applied to the production of antibodies that target proteins in other species. We have already begun cloning target genes in dogs, and will begin production of recombinant dog proteins, cell lines, and mAbs in 2016. The devil immunology group will develop dog-specific mAbs, and perform in vitro testing functional testing of the mAbs. The first batch of antibodies for PETization? will be delivered to Nexvet in January, 2017. The initial functional testing of the antibodies performed by the devil immunology team will generate vital preliminary data to support planned ARC Linkage Project application in 2016-2017 in order to leverage funds for ongoing collaborative research. Establishing a solid connection between Nexvet and the devil immunology team prior to submission of the ARC Linkage Project application will greatly increase the probability receiving a Linkage Project award and leveraging funds. This research could help save an iconic Australian animal from extinction, develop immunotherapeutics to improve and extend the lives of pets around the world, and help to drive an emerging market for pharmaceuticals for pets. Funded by: Department of Industry, Science, Energy and Resources ($50,000); Nexvet Australia Pty Ltd ($90,000); University of Tasmania.
  • CONSULTANCY/CONTRACT RESEARCH
    Immunological approach to protect Tasmanian devils against devil facial tumour disease
    University of Tasmania Foundation Inc1 Aug 2015 - 31 Dec 2021
    People funded by this grant:
    • Lyons AB,
    • Kreiss A,
    • Woods GM,
    • Pye RJ,
    • Flies A
    Project Total: $139,262; This project is aimed at refining our immunisation procedure that stimulates the devil's immune system to recognise and kill DFTD tumour cells. Funded by: University of Tasmania Foundation Inc ($139,262)
  • GRANT
    Up-regulating MHC expression of DFTD cells in vivo by treating established tumours with imiquimod
    17 Mar 2015 - 31 Dec 2016
    People funded by this grant:
    • Pinfold T,
    • Bettiol S,
    • Woods G
    Project Total: $28,000; DFTD cells avoid immune recognition and destruction because they turn off important genes. Recent research discovered that imiquimod, a drug used to treat skin cancer, can turn on these genes. This project will determine if imiquimod makes DFTD cells visible to the Tasmanian devil's immune system, thereby inducing an immune response. Funded by: University of Tasmania Foundation Inc - Grant-Dr Eric Guiler Tasmanian Devil Research Gran; University of Tasmania ($28,000).
  • GRANT
    Can DFTD cells be made visible to the Tasmanian devil immune system?
    13 Mar 2015 - 13 Jun 2016
    People funded by this grant:
    • Lyons B,
    • Woods G
    Project Total: $28,000; DFTD should be recognised and rejected by the Tasmanian devil's immune system as a foreign graft, but it appears to be invisible. This project aims to discover if re-expression of MHC molecules allows DFTD cells to be recognised as an allograft and ultimately be killed by the devil immune system. In vitro cell culture techniques and flow cytometry will be used to examine responses. The demonstration that tumour cells can be recognized by cytotoxic T cells will aid the design of immune based strategies for prevention and therapy. Funded by: University of Tasmania Foundation Inc - Grant-Dr Eric Guiler Tasmanian Devil Research Gran; University of Tasmania ($28,000).
  • GRANT
    Vaccination of Tasmanian devils to induce a memory response against DFTD
    13 Mar 2015 - 13 Jun 2016
    People funded by this grant:
    • Kreiss A,
    • Woods G,
    • Pye R
    Project Total: $29,000; This project will test whether a newly developed vaccination strategy will protect the Tasmanian devil from acquiring the deadly Devil Facial Tumour Disease (DFTD). The vaccination consists of a series of booster immunisations, similar to the chicken pox vaccine, that aims to prime the devil's memory immune response to recognise and eradicate invading tumour cells. The project will provide valuable knowledge as to whether the vaccine and long-term booster injection will protect devils from DFTD. Results will be communicated with the scientific and public community by scientific presentations, conference presentations, community presentations and media releases. Funded by: University of Tasmania Foundation Inc - Grant-Dr Eric Guiler Tasmanian Devil Research Gran; University of Tasmania ($29,000).
  • GRANT
    Co-signalling immunotherapy to treat DFTD
    1 Sep 2014 - 31 Aug 2016
    People funded by this grant:
    • Woods G,
    • Flies A
    Project Total: $99,360; Immunotherapies targeting immune signalling molecules have recently yielded unprecedented results in treating human cancer. The genes targeted in these ground-breaking trials have been identified in devils. This study will assess the potential for translating the already proven human therapies into a treatment for the DFTD. This research aims to determine if DFTD cells can be modified to induce cytotoxic lymphocyte activity which has the potential to be used as therapy to treat devil facial tumour disease. Funded by: Morris Animal Foundation - Fellowship ($99,360); University of Tasmania.
  • GRANT
    Co-signalling immunotherapy to treat DFTD
    1 May 2014 - 30 Apr 2015
    People funded by this grant:
    • Flies A,
    • Woods G
    Project Total: $20,000; Immunotherapies targeting immune signalling molecules have recently yielded unprecedented results in treating human cancer. The genes targeted in these ground-breaking trials have been identified in devils; this study will assess the potential for translating the already proven human therapies into treatment for the DFTD. Funded by: University of Tasmania Foundation Inc - Grant-Dr Eric Guiler Tasmanian Devil Research Gran; University of Tasmania ($35,000).
  • GRANT
    Development of an immune enhancing vaccine to protect Tasmanian devils against a contagious cancer
    31 Mar 2014 - 14 Apr 2017
    People funded by this grant:
    • Woods G,
    • Lyons B
    Project Total: $412,912; The iconic Tasmanian devil is threatened with extinction from a uniformly fatal transmissible facial cancer. This project builds on existing research on the cancer cells that can be recognised by the devil immune system. It will develop and test a vaccine against the tumour, which will ultimately protect devils in the wild. Funded by: Australian Research Council - Grant-Linkage Projects Round 1 ($412,912); University of Tasmania.